- Home
- CTO vs GRAL Comparison
CTO vs GRAL Comparison
Compare CTO & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTO
- GRAL
- Stock Information
- Founded
- CTO 1902
- GRAL 2016
- Country
- CTO United States
- GRAL United States
- Employees
- CTO N/A
- GRAL N/A
- Industry
- CTO Real Estate Investment Trusts
- GRAL
- Sector
- CTO Real Estate
- GRAL
- Exchange
- CTO Nasdaq
- GRAL NYSE
- Market Cap
- CTO 578.8M
- GRAL 610.9M
- IPO Year
- CTO N/A
- GRAL N/A
- Fundamental
- Price
- CTO $19.22
- GRAL $17.34
- Analyst Decision
- CTO Strong Buy
- GRAL Hold
- Analyst Count
- CTO 4
- GRAL 2
- Target Price
- CTO $21.50
- GRAL $16.00
- AVG Volume (30 Days)
- CTO 452.3K
- GRAL 970.8K
- Earning Date
- CTO 02-20-2025
- GRAL 02-15-2025
- Dividend Yield
- CTO 7.95%
- GRAL N/A
- EPS Growth
- CTO N/A
- GRAL N/A
- EPS
- CTO 0.61
- GRAL N/A
- Revenue
- CTO $118,662,000.00
- GRAL $117,669,000.00
- Revenue This Year
- CTO N/A
- GRAL $32.48
- Revenue Next Year
- CTO $13.12
- GRAL $14.72
- P/E Ratio
- CTO $31.56
- GRAL N/A
- Revenue Growth
- CTO 16.61
- GRAL 111.83
- 52 Week Low
- CTO $16.16
- GRAL $12.33
- 52 Week High
- CTO $21.15
- GRAL $24.92
- Technical
- Relative Strength Index (RSI)
- CTO 35.77
- GRAL N/A
- Support Level
- CTO $19.25
- GRAL N/A
- Resistance Level
- CTO $19.74
- GRAL N/A
- Average True Range (ATR)
- CTO 0.37
- GRAL 0.00
- MACD
- CTO -0.07
- GRAL 0.00
- Stochastic Oscillator
- CTO 2.03
- GRAL 0.00
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a Florida-based real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.